aap Implantate AG
Lorenzweg 5
Berlin 12099
Germany
49 30 75019 0
https://www.aap.de
版塊: Healthcare
行業: Medical Devices
全職員工: 111
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Rubino Di Girolamo | Chairman of the Management Board & CEO | 205k | 無 | 1962 |
| Ms. Agnieszka Mierzejewska | Member of Management Board & COO | 無 | 無 | 1983 |
| Fabian Franke | Head of Investor Relations | 無 | 無 | 無 |
截止 2020年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。
描述
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, and shoulder; and a range of cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany, and through a network of distributors internationally. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
公司管治
截至 無 止，aap Implantate AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
